U.S. drugmaker Eli Lilly & Co. has introduced Mounjaro in India, the country's first treatment of its kind for obesity, with monthly costs ranging from $168 to $210. The medication is approved for weight loss in patients both with and without type-2 diabetes. Industry experts anticipate competition to intensify soon...